Endovascular stenting for intracranial venous hypertension caused by meningioma: A case series and systematic literature review

Thomas Courret, Xavier Barreau, Julien Engelhardt, Vincent Jecko, Omer Eker, Emilie Tournaire-Marques, Thomas Tourdias, Gaultier Marnat
Journal of Neuroradiology. 2025-05-01; 52(3): 101335
DOI: 10.1016/j.neurad.2025.101335

PubMed
Lire sur PubMed


https://www.bordeaux-neurocampus.fr/12320

Courret T(1), Barreau X(2), Engelhardt J(3), Jecko V(4), Eker O(2),Tournaire-Marques E(5), Tourdias T(6), Marnat G(2).

Author information:
(1)Neuroradiology Department, CHU Bordeaux, Postal Address: 1, Place Amélie Raba
Léon, Bordeaux 33000, France. Electronic address: .
(2)Neuroradiology Department, CHU Bordeaux, Postal Address: 1, Place Amélie Raba
Léon, Bordeaux 33000, France.
(3)Neurocentre Magendie, INSERM-U1215, Bordeaux, France.
(4)Neurosurgery Department, CHU Bordeaux, Bordeaux, France.
(5)Ophtalmology Department, CHU Bordeaux, Bordeaux, France.
(6)Neuroradiology Department, CHU Bordeaux, Postal Address: 1, Place Amélie Raba
Léon, Bordeaux 33000, France; Neurocentre Magendie, INSERM-U1215, Bordeaux,
France.

BACKGROUND & PURPOSE: Venous intracranial hypertension is defined as an
increased intracranial pressure secondary to venous congestion. Specific causes
of venous hypertension can be identified, including extrinsic venous sinus
compression or invasion by intracranial tumors such as meningioma. We aimed to
report a case series of four patients with symptomatic venous intracranial
hypertension secondary to meningioma and treated with stenting. We also
performed a systematic literature review.
METHODS: The local case series included consecutive patients with symptomatic
venous intracranial hypertension who underwent venous sinus stenting in our
center between January 2010 and June 2024. Initial clinical presentation,
imaging data, treatment details and long-term outcomes were presented. A
systematic literature review was performed according to PRISMA guidelines up to
June 2024.
RESULTS: Four patients were treated in our center during the study period. In
all cases, stenting was adequately performed without complication. Patients
experienced substantial and durable clinical improvement, including papilledema
resorption. Eight publications were included in the literature review (28
patients). Including our 4 reported cases, a total of 32 patients were analyzed
in the systematic review. Complete symptoms recovery occurred in 25 patients
(78.1 %) and a partial resolution in 7 (21.9 %). Twelve patients received
adjuvant radiotherapy, two of whom also underwent surgery. Five patients
presented clinical recurrence and required endovascular retreatment. No
complications were reported.
CONCLUSION: In the setting of a compression or invasion due to a meningioma,
stenting of symptomatic intracranial venous stenoses appeared as a safe and
promisingly effective option.

Copyright © 2025 Elsevier Masson SAS. All rights reserved.

DOI: 10.1016/j.neurad.2025.101335
PMID: 40049399 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of competing interest The authors
declare that they have no known competing financial or personal relationships
that could be viewed as influencing the work reported in this paper.

Auteurs Bordeaux Neurocampus